EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between MTHFR C677T Gene Polymorphisms and the Efficacy of Vitamin Therapy in lowering Homocysteine Levels among Stroke Patients with Hyperhomocysteinemia

Zhi-Can Li, Min Huang, Qing-Yang Yao, Cai-Hong Lin, Bing-Cong Hong, Jie-Hua Wang, Zedan Zhang

Journal of Integrative Neuroscience · 2024

DOI: 10.31083/j.jin2301003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Integrative Neuroscience, 2024. Verfasst von Zhi-Can Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Quanzhou First Hospital Affiliated to Fujian Medical University, 362000 Quanzhou, Fujian, China. Hauptthemen laut MEDLINE: Hyperhomocysteinemia, Stroke. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The impact of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation on the relationship between plasma homocysteine (Hcy) levels and stroke has been extensively studied and documented in previous study. However, it remains unclear whether the MTHFR C677T mutation can affect the response to Hcy lowering treatment in stroke patients with hyperhomocysteinemia (HHcy). Understanding the impact of genetic factors on treatment response can help optimize personalized treatment strategies for stroke patients with HHcy. We aimed to investigate the potential association between the MTHFR C677T gene polymorphisms and the effectiveness of Hcy lowering treatment using vitamin therapy in stroke patients with HHcy.

Methods

The MTHFR C677T genotype polymorphisms were identified using polymerase chain reaction-restriction fragment length polymorphism, and the distribution of three genotypes in the MTHFR C677T gene locus was compared. The treatment effects of Hcy lowering agents were compared among patients with different genotypes.

Results

Among the 320 stroke patients enrolled in the study, 258 (80.6%) were diagnosed with HHcy. Of these, 162 patients (Effective Group) responded well to the clinical Hcy lowering treatment, while 96 patients (Invalid Group) failed to achieve sufficient response even after taking combination supplements of folic acid, Vitamin B6, and methylcobalamin for one month. Significant differences were observed in terms of age (p < 0.001), hypertension (p = 0.034), dyslipidemia (p = 0.022), hyperuricemia (p = 0.013) and genotype distribution of MTHFR C677T gene polymorphism (p < 0.001) between the Invalid group and the Effective group. The multivariate regression analysis revealed that the T allele (odd rations [OR], 1.327; 95% confidence interval [CI], 1.114–1.580; p = 0.0015) was independently associated with an insufficient Hcy lowering treatment effect. Additionally, the TT genotype was independently associated with insufficient response in both the codominant model (OR, 1.645; 95% CI, 1.093–2.476; p = 0.017) and the recessive model (TT versus CC + CT; OR, 1.529; 95% CI, 1.145–2.042; p = 0.004). However, no relationship was observed between CT + TT genotypes and poor treatment effect in the dominate model.

Conclusions

Our findings suggested that the TT genotype and T allele of MTHFR C677T polymorphism were independently associated with an insufficient Hcy lowering treatment effect in stroke patients with HHcy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperhomocysteinemiaStrokeHumansPolymorphism, GeneticMethylenetetrahydrofolate Reductase (NADPH2)HomocysteineVitamins

Stichwörter der Autor:innen

homocysteinemethylenetetrahydrofolate reductasesingle nucleotide polymorphismstroke

Substanzen

Methylenetetrahydrofolate Reductase (NADPH2)HomocysteineVitaminsMTHFR protein, human

Autor:innen und Institutionen

  • Department of Neurology, Quanzhou First Hospital Affiliated to Fujian Medical University, 362000 Quanzhou, Fujian, China.
  • Department of Geriatrics, The 900th Hospital of Joint Logistics Support Force of Chinese PLA, 350025 Fuzhou, Fujian, China.
  • Department of Health Medicine, The 900th Hospital of Joint Logistics Support Force of Chinese PLA, 350025 Fuzhou, Fujian, China.

Zitieren

APA

Li, Z. C., Huang, M., Yao, Q. Y., Lin, C. H., Hong, B. C., Wang, J. H., & Zhang, Z. (2024). Association between MTHFR C677T Gene Polymorphisms and the Efficacy of Vitamin Therapy in lowering Homocysteine Levels among Stroke Patients with Hyperhomocysteinemia. Journal of Integrative Neuroscience. https://doi.org/10.31083/j.jin2301003

Vancouver

Li ZC, Huang M, Yao QY, Lin CH, Hong BC, Wang JH, et al. Association between MTHFR C677T Gene Polymorphisms and the Efficacy of Vitamin Therapy in lowering Homocysteine Levels among Stroke Patients with Hyperhomocysteinemia. Journal of Integrative Neuroscience. 2024. doi:10.31083/j.jin2301003

BibTeX
@article{Li2024,
  author = {Li, Zhi-Can and Huang, Min and Yao, Qing-Yang and Lin, Cai-Hong and Hong, Bing-Cong and Wang, Jie-Hua and Zhang, Zedan},
  title = {Association between MTHFR C677T Gene Polymorphisms and the Efficacy of Vitamin Therapy in lowering Homocysteine Levels among Stroke Patients with Hyperhomocysteinemia},
  journal = {Journal of Integrative Neuroscience},
  year = {2024},
  doi = {10.31083/j.jin2301003}
}
Kostenlos starten →